U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030

U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030


Portable Lithium Power Station Market Growth & Trends

The global portable lithium power station market size is expected to reach USD 396.4 million by 2030, according to a new study conducted by Grand View Research, Inc. It is expected to expand at a CAGR of 16.8% from 2025 to 2030. With the improvement in battery technology, coupled with the increasing demand for portable power packs from the consumer electronics sector for powering notebooks, mobiles, tablets, and other smart devices, the demand for portable lithium power stations is anticipated to grow over the forecast period. Additionally, the rising demand for portable lithium power stations in a variety of application areas, including automotive, off-grid, and emergency power, is expected to create significant opportunities for the vendors operating in the market over the forecast period.

The key factors driving the market are the increasing penetration of smart electronic devices, rising demand for reliable and uninterrupted power, and stringent emission rules across regions. Moreover, the stringent regulations made by the government bodies on carbon emission and the growing adoption of advanced technologies by the customers are the key challenges faced by the vendors with regards to manufacturing the products that are planned with the latest demanding features and applications, which surely limits the market from expanding its reach.

The market is served by a blend of large players with international presence and capabilities to serve customers from different regions and local and domestic players that are having a strong foothold in the local markets. The key strategies adopted by these players include product launches, product development, expansions & investments, and partnerships and collaborations. New product development and launches were the most common strategies adopted in the past few years by the majority of vendors operating in the market. Moreover, partnerships and collaborations were another majorly adopted strategy by vendors to reinforce their product and service offerings and footprints across the globe. However, a decrease in the sales of electric vehicles, coupled with imposed restrictions on tourism and travel during the COVID-19 situation, is hindering the market growth. Asia Pacific is expected to witness substantial growth over the forecast period owing to the rising demand for portable lithium power stations to ensure continuous power supply during power outages, outdoor recreational activities, and camping in China, India, and Japan

Portable Lithium Power Station Market Report Highlights
  • By type, the solar power segment is anticipated to witness significant growth in the years to come owing to the increasing emphasis on the use of renewable energy
  • The 1,000 Wh to 1,499 Wh capacity segment is anticipated to witness high growth as 1,000 Wh to 1,499 Wh power stations are increasingly used for powering large-sized devices and equipment along with multiple smaller devices, such as smartphones, tablets, and laptops
  • The e-commerce sales channel segment is anticipated to witness significant growth over the forecast period owing to the growing penetration of digital platforms for transactions, coupled with the rising number of smartphone users
  • The off-gird application segment is anticipated to register the highest CAGR over the forecast period owing to the increasing outdoor recreational and camping activities across the globe, which is expected to create healthy demand for portable lithium power stations to fulfill the power requirements at remote locations
  • The industrial end-use segment is expected to grow at a significant rate over the forecast period owing to the growing need for continuous power and the availability of industrial-grade portable lithium power station
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Scope
1.1.2. Estimates And Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Global Market: CAGR Calculation
1.7. Research Scope and Assumptions
1.7.1. List of Secondary Sources
1.7.2. List of Primary Sources
1.7.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Animal Health Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising Prevalence of Animal Diseases
3.2.1.2. Growing Uptake Of Pet Insurance
3.2.1.3. Increase In Pet Population & Pet Humanization
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of treatment
3.2.2.2. Adverse effects associated with therapies
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. U.S. Animal Health Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal landscape
3.4. Covid-19 Analysis
3.5. Estimated Pet Population by key countries
Chapter 4. U.S. Animal Health Market: Animal Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Animal Health Market Movement Analysis
4.3. U.S. Animal Health Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
4.3.1. Production Animals
4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.2. Poultry
4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.3. Swine
4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.4. Cattles
4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.5. Sheep & Goats
4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.1.6. Fish
4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Companion Animals
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Dogs
4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Cats
4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Horses
4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2.5. Others
4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Animal Health Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Animal Health Market Movement Analysis
5.3. U.S. Animal Health Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.3.1. Biologics
5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2. Vaccines
5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.2. Attenuated Live Vaccines
5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.3. Inactivated Vaccines
5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.4. Subunit Vaccines
5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5. DNA Vaccines
5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.2. Recombinant Vaccines
5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.4. Autogenous Vaccines
5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.1.2.5.6. Other Biologics
5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Pharmaceuticals
5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Parasiticides
5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Anti-infectives
5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Anti-inflammatory
5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.5. Analgesics
5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.6. Other Pharmaceuticals
5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Medicinal Feed Additives
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Animal Health Market: Type of Vaccine Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Animal Health Market Movement Analysis
6.3. U.S. Animal Health Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
6.3.1. Cattle Vaccine
6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2. Porcine Vaccine
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3. Poultry Vaccine
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4. Aquaculture Vaccine
6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.5. Other Vaccines
6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Animal Health Market: Disease Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Animal Health Market Movement Analysis
7.3. U.S. Animal Health Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
7.3.1. Cattle Disease
7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.2. Porcine Disease
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.3. Poultry Disease
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.4. Aquaculture Disease
7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
7.3.5. Other Disease
7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Animal Health Market: Route of Administration Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Animal Health Market Movement Analysis
8.3. U.S. Animal Health Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
8.3.1. Oral
8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2. Injectable
8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.2. Subcutaneous
8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.3. Intramuscular
8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2.4. Intravenous
8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3. Topical
8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.4. Other
8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. U.S. Animal Health Market: Distribution Channel Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. U.S. Animal Health Market Movement Analysis
9.3. U.S. Animal Health Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
9.3.1. Retail
9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2. E-Commerce
9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.3. Hospital/ Clinic Pharmacy
9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Company Market Position Analysis/ Heat Map Analysis
10.3. Strategy Mapping
10.3.1. Mergers & Acquisitions
10.3.2. Partnerships & Collaborations
10.3.3. Others
10.4. Company Profiles
10.4.1. Zoetis Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Ceva Santé Animale
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Merck & Co., Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. Vetoquinol S.A.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Boehringer Ingelheim Gmbh
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Elanco Animal Health Incorporated
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Virbac
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. Phibro Animal Health Corporation
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Dechra Pharmaceuticals Plc
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Bimeda, Inc.
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Cargill, Incorporated.
10.4.11.1. Participant’s Overview
10.4.11.2. Financial Performance
10.4.11.3. Product Benchmarking
10.4.11.4. Strategic Initiatives
10.4.12. Aurora Pharmaceutical, Inc.
10.4.12.1. Participant’s Overview
10.4.12.2. Financial Performance
10.4.12.3. Product Benchmarking
10.4.12.4. Strategic Initiatives
10.4.13. Calier
10.4.13.1. Participant’s Overview
10.4.13.2. Financial Performance
10.4.13.3. Product Benchmarking
10.4.13.4. Strategic Initiatives
Chapter 11. Key Takeaways

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings